Indian Exemestane Exporters: Complete Supplier Ranking with Market Share — 196 Manufacturers (2026) — TransData Nexus

Q: Who is the largest exemestane buyer importing from India?

CARDINAL HEALTH (UNITED STATES) is the largest exemestane importer from India with a 7.5% market share and import value of $1.1M.

Q: How many exemestane buyers import from India?

There are 196 active exemestane buyers importing from India, with a combined import market of $14.5M across 1,533 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top exemestane buyers from India?

The top 5 exemestane buyers — CARDINAL HEALTH, AUROBINDO PHARMA USA., INC,, BROCACEF NL HUB, FIEGE HEALTHCARE LOGISTICS GMBH, CIPLA USA INC UPS SUPPLY CHAIN SOLU — together control 25.4% of total exemestane import value from India.

Suresh Sormare

Exemestane

India Pharmaceutical Trade Intelligence

$14.5M87 Suppliers57 CountriesHS 30049049

ExportsIndia → UNITED STATES39.3%India → BRAZIL12.2%

ImportsUNITED STATES → India$163.0K ITALY → India$146.4K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: CARDINAL HEALTH

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $5.7M through 60 shipments. This represents a market share of 39.3% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• CARDINAL HEALTH - $1.1M (19.0% of country's total business)

• AUROBINDO PHARMA USA., INC, - $709.8K (12.5% of country's total business)

• CIPLA USA INC UPS SUPPLY CHAIN SOLU - $586.8K (10.3% of country's total business)

• XXDUSXXHARXXCEUXXCALXXUSAXXNC - $582.2K (10.2% of country's total business)

• AUROBINDO PHARMA USA INC - $524.4K (9.2% of country's total business)

• Rest of United States's importers - $2.2M (38.7% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $94.8K, indicating premium pricing strategy compared to the market average of $9.4K.

United States is a key market for Exemestane imports, representing 39.3% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Exemestane buyer market intelligence

1Buyer Segment Analysis

The 196 buyers of Exemestane from India can be categorized into several segments:

1. Distributors: Entities like Cardinal Health (United States, $1.08M) and Brocacef NL Hub (Netherlands, $0.70M) fall into this category. These organizations purchase large quantities to supply pharmacies, hospitals, and clinics. Their buying behavior typically involves bulk orders to leverage economies of scale, with a focus on maintaining a consistent supply chain to meet market demand.

2. Pharmaceutical Companies: Companies such as Aurobindo Pharma USA, Inc. (United States, $0.71M) and Cipla USA Inc. (United States, $0.59M) import Exemestane for further distribution or inclusion in their product portfolios. Their procurement patterns are influenced by market demand forecasts, regulatory approvals, and competitive positioning.

3. Logistics and Healthcare Service Providers: Organizations like Fiege Healthcare Logistics GmbH (Germany, $0.60M) specialize in the storage and distribution of pharmaceuticals. They procure Exemestane to fulfill contracts with healthcare providers, ensuring timely delivery and compliance with storage requirements.

4. Retail Chains and Hospital Groups: While not explicitly listed among the top buyers, these entities procure Exemestane to meet patient needs. Their purchasing decisions are driven by treatment protocols, patient demographics, and formulary inclusions.

5. Re-exporters: Some buyers may act as intermediaries, importing Exemestane for re-export to other markets. Their procurement is influenced by global demand trends and trade regulations.

6. Government Procurement Agencies: Entities involved in national tenders or international health programs may also be buyers, focusing on bulk purchases to supply public health facilities. Their buying behavior is characterized by adherence to tender specifications, pricing negotiations, and compliance with regulatory standards.

Country-Specific Import Regulations

TransData Nexus Exemestane buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Exemestane are as follows:

1. United States:

Regulatory Authority: Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Exemestane is approved by the FDA. This involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic versions.

Estimated Timeline for Registration: The NDA process can take 6 to 10 months, while the ANDA process may take 10 months or more, depending on the complexity and completeness of the application.

Import Tariff/Duty for HS 30049049: Pharmaceutical products under this HS code are generally duty-free in the United States.

2. Brazil:

Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA).

Demand Drivers & Market Opportunity

TransData Nexus Exemestane buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Exemestane in importing countries is primarily driven by the prevalence of hormone receptor-positive breast cancer, for which Exemestane is a standard treatment. According to the World Health Organization (WHO), breast cancer remains the most common cancer among women worldwide, with approximately 2.3 million new cases diagnosed in 2025. Government healthcare programs and the expansion of universal health coverage have increased access to cancer treatments, further driving demand.

Additionally, Exemestane's inclusion in the WHO Model List of Essential Medicines underscores its importance in cancer treatment protocols. This inclusion facilitates procurement through international health programs and tender-based purchasing, ensuring broader accessibility. The presence of 196 buyers across 57 countries, as per TransData Nexus data, indicates a robust and diverse market for Exemestane, presenting significant opportunities for suppliers to meet the global demand for this essential medication.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Exemestane Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest exemestane buyer importing from India?

Based on import volume and value, CARDINAL HEALTH (UNITED STATES) leads with $1.1M in imports and a 7.5% market share — the highest of any single exemestane importer. AUROBINDO PHARMA USA., INC, (UNITED STATES) and BROCACEF NL HUB (NETHERLANDS) are the next largest buyers.

QHow many companies buy exemestane from India?

There are 196 active exemestane buyers importing from India, with a combined market of $14.5M across 1,533 shipments to 57 countries. The top 5 buyers hold 25.4% of total import value, while the remaining 191 buyers handle the other 74.6%.

QWhich countries import the most exemestane from India?

The top importing countries for exemestane from India are United States (39.3%), Brazil (12.2%), Netherlands (11.7%), United Kingdom (9.7%), Germany (6.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of exemestane, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for exemestane from India?

The average import transaction value for exemestane from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Exemestane buyer market intelligence

1Buyer Segment Analysis

The 196 buyers of Exemestane from India can be categorized into several segments:

5. Re-exporters: Some buyers may act as intermediaries, importing Exemestane for re-export to other markets. Their procurement is influenced by global demand trends and trade regulations.

Country-Specific Import Regulations

TransData Nexus Exemestane buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Exemestane are as follows:

1. United States:

Regulatory Authority: Food and Drug Administration (FDA).

Estimated Timeline for Registration: The NDA process can take 6 to 10 months, while the ANDA process may take 10 months or more, depending on the complexity and completeness of the application.

Import Tariff/Duty for HS 30049049: Pharmaceutical products under this HS code are generally duty-free in the United States.

2. Brazil:

Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA).

Demand Drivers & Market Opportunity

TransData Nexus Exemestane buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Exemestane

Exemestane

Who Buys Exemestane from India — 196 Importers Behind a $14.5M Market

Top Exemestane Importers — Ranked by Import Value

Top Exemestane Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Exemestane — and from which countries?

Exemestane — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Exemestane Buyers & Importers

QWho is the largest exemestane buyer importing from India?

QHow many companies buy exemestane from India?

QWhich countries import the most exemestane from India?

QWhat is the average import order value for exemestane from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Brazil

3Netherlands

4United Kingdom

5Germany

Analysis Methodology